Navigation Links
Omeros Announces National Institute on Drug Abuse's Support for Phase 2 Clinical Study in Addiction Program
Date:1/28/2010

program.

"NIDA's support for this study marks an important step forward for our program and validates its potential to prevent addiction and to treat patients suffering from substance abuse," stated Gregory Demopulos, M.D., Chairman and CEO of Omeros. "We recognize that the investigators and NIDA moved quickly and we appreciate their financial and operational support."

"Our team looks forward to getting patients enrolled in this study as soon as possible," stated Dr. Comer. "Addiction to opioids and other substances is a major public health problem, and the data from Omeros' preclinical and pilot clinical studies show that PPAR-gamma agonist therapy holds significant promise as an effective treatment."

About Omeros Corporation

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery™ clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.

For more information on Omeros, visit the Company's website at www.omeros.com.


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daniel K. Spiegelman Elected to Board of Directors of Omeros
2. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
3. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
4. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
5. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
6. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
7. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
8. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
9. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
10. CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer
11. NeuIsys Announces Entrance into the Gastroenterology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  Marken, the leading clinical ... life sciences industry, has been granted permission by the ... of clinical drug product in Korea.  This precedent-setting shipment ... to continue receiving their clinical trial drugs ... The emergency was caused by recent partial ...
(Date:6/30/2015)... , June 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... its 2015 Annual Meeting of StockholdersWhen:Tuesday, June 30 at ... on the Internet.  Simply log onto our website listed ... participate during the live event, a replay of the ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging ... Paper, Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, ... - By Geographical Region ( North America , ... , Latin America , Middle ... discussing Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, ...
Breaking Medicine Technology:Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
(Date:6/30/2015)... ... June 30, 2015 , ... Micro Com Systems ... high quality record management services for patient records. Medical imaging includes services such ... physicians and clinics. , With the increase in the acceptance level of ...
(Date:6/30/2015)... ... 2015 , ... Harbor Village Detox is a drug and ... on June 12th. Holly Vasquez-Cortella was recently quoted as an expert in the addiction ... on trending addiction news and treatment innovations. The article highlights Florida governor Rick Scott’s ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Due to today’s housing market, many people cannot ... difficult as they have to make adjustments as to how to carry laundry or groceries ... have laundry facilities in the basement or first floor of the home, and the bedrooms ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to 80% of ... can range from a dull, constant ache (chronic) to a sudden sharp pain (acute). ... injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & Regenerative Medicine ...
(Date:6/30/2015)... ... June 30, 2015 , ... New Xarelto lawsuit claims proposed ... of new forms, according to attorneys handling Xarelto lawsuits included in ... Complaint, “provide guidance” for plaintiffs’ attorneys in filing new claims, according to court ...
Breaking Medicine News(10 mins):Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3
... women between the ages of 18 and 24 are smokers, and ... But researchers at Temple University have found that when it ... be more effective than an exercise plan in helping women not ... lot of college--age women report smoking to keep their weight down ...
... a national organization, will recognize World Meningitis Day (WMD) by ... was founded in memory of Ryan Milley, the only child ... include over 600 families in the U.S. and some 30+ ... also works very hard as a children,s health and immunization ...
... and elephantjournal columnist Brigitte Mars weighs in on ... measure doing more harm than good? Should we ... Waylon Lewis, editor-in-chief at eco, spiritual, irreverent ... Huffington Post ( http://www.huffingtonpost.com/waylon-lewis/what-do-newmans-own-endan_b_188001.html ...
... inflammatory demyelinating polyneuropathy (CIDP) depend on plasma donationANNAPOLIS, ... inflammatory demyelinating polyneuropathy (CIDP) is a debilitating, ... and fatigue and can severely impair motor skills. ... two to seven individuals per 100,000 worldwide. The ...
... Corporation of America (Nasdaq: DCAI ) announced today ... on Tuesday, May 5, 2009, after the close of the ... conjunction with its first quarter 2009 earnings release the following ... interested in participating in the May 6, 2009 conference call ...
... patients, financial responsibility for their diabetes therapy, positively ... in real time at point of dispensing ACCU-CHEK(R) ... the launch of its new eVoucherRx(TM) pilot program ... patients with diabetes to receive their co-pay savings ...
Cached Medicine News:Health News:Mind over muscle 2Health News:World Meningitis Day in Texas 2Health News:elephantjournal.com: Is Fluoridating Waters Giving Kids Cavities? 2Health News:CIDP Treated With Plasma-Derived Therapy 2Health News:CIDP Treated With Plasma-Derived Therapy 3Health News:Dialysis Corporation of America Announces First Quarter 2009 Earnings Release Date 2Health News:Roche Announces New Co-Pay Program in California That Makes it Easier for Patients With Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips 2Health News:Roche Announces New Co-Pay Program in California That Makes it Easier for Patients With Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips 3
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Medium 23 mm. Overall length: 3.9 inches....
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Short 19 mm. Overall length: 3.9 inches....
Size 2 dilator. Stainless steel. Round knurled handle with polished finish. Overall length: 4 inches....
Double ended dilator probes with gentle curve. Stainless steel. Round knurled handle with polished finish. Overall length: 5.3 inches....
Medicine Products: